Degeneração macular, perda de visão central

Authors

  • Miguel Bombonato de Araújo
  • Sophia Pontes Garcia Unicesumar
  • Eleniza de Victor Adamowski

DOI:

https://doi.org/10.36557/2674-8169.2026v8n6p692-703

Keywords:

Degeneração macular, envelhecimento, perda visual, fatores de estresse oxidativo, terapia anti-VEGF

Abstract

Macular degeneration is one of the main causes of irreversible visual loss in older adults, representing an important public health problem due to population aging. The disease has a significant impact on quality of life, compromising daily activities and the autonomy of affected individuals. In this context, it is essential to understand its clinical aspects, risk factors, and therapeutic approaches. The present study aims to analyze, through the scientific literature, the main factors associated with macular degeneration, as well as its clinical implications and management strategies. This is an integrative literature review, with searches conducted in the SciELO, PubMed, and LILACS databases. Descriptors related to macular degeneration were used.

As inclusion criteria, articles published between 2015 and 2025 were considered. After screening titles, abstracts, and full-text articles, studies were selected for qualitative analysis. The results show that macular degeneration has a multifactorial etiology, involving genetic factors, aging, oxidative stress, and lifestyle habits. In addition, advances in therapeutic strategies have been observed, especially with anti-VEGF therapies, although limitations still remain regarding a definitive treatment for the disease. It is concluded that analyzing the pathophysiological, structural, and clinical aspects is essential for the development of preventive and therapeutic strategies, contributing to the reduction of the disease's impact on the older adult population.

Downloads

Download data is not yet available.

References

APTE RS. Age-Related Macular Degeneration. N Engl J Med. 2021 Aug 5;385(6):539-547.

doi: 10.1056/NEJMcp2102061. PMID: 34347954; PMCID: PMC9369215.

FLECKENSTEIN M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S,

Klaver CC, Wong WT, Chew EY. Age-related macular degeneration. Nat Rev Dis Primers.

May 6;7(1):31. doi: 10.1038/s41572-021-00265-2. PMID: 33958600; PMCID:

PMC12878645.

FLECKENSTEIN M, Schmitz-Valckenberg S, Chakravarthy U. Age-Related Macular

Degeneration: A Review. JAMA. 2024 Jan 9;331(2):147-157. doi:

1001/jama.2023.26074. PMID: 38193957; PMCID: PMC12935482.

GARCIA-GARCIA J, Ustegui-Martin R, Sanabria MR, Fernandez-Perez E, Telleria JJ, Coco-

Martin RM. Pathophysiology of Age-Related Macular Degeneration: Implications for

Treatment. Ophthalmic Res. 2022;65(6):615-636. doi: 10.1159/000524942. Epub 2022

May 25. PMID: 35613547.

GHEORGHE A, Mahdi L, Musat O. AGE-RELATED MACULAR DEGENERATION. Rom J

Ophthalmol. 2015 Apr-Jun;59(2):74-7. PMID: 26978865; PMCID: PMC5712933.

JIANG F, Ma J, Lei C, Zhang Y, Zhang M. Age-Related Macular Degeneration: Cellular and Molecular Signaling Mechanisms. Int J Mol Sci. 2025 Jun 26;26(13):6174. doi:

3390/ijms26136174. PMID: 40649951; PMCID: PMC12249930.

MATOS LS, Fasciani MPS, Simões PS, Ferreira B de RS, Santos TV de O, Freires MF.

Degeneração macular relacionada à idade. JMBR. 2025 Mar 12 [cited 2026 Apr

;2(2):218-36.

NGUYEN J, Brantley MA Jr, Schwartz SG. Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians. Front Biosci (Schol Ed). 2024 Feb 29;16(1):3. doi:10.31083/j.fbs1601003. PMID: 38538345.

PINA GC, Barreto LM, Vieira RM, Tomaz PN, Teixeira JPCR, Ferreira AR, Fraga MSG, Santos JC dos, Ribeiro GR de B, Couto LA, Sena, M. Ângelo A., Basílio IG, Almeida ALC, Pina LC, Portilho JVM, Jayme BC. Degeneração macular relacionada à idade: uma visão geral e atualizações: Age-related macular degeneration: an overview and updates. Braz J Develop. 2022 Nov 4 [cited 2026 Apr 2];8(11):71394-408.

SABETI F, Lane J, Rohan EMF, Rai BB, Essex RW, McKone E, Maddess T. Correlation of

Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration. Transl Vis Sci Technol. 2021 Feb 5;10(2):10. doi: 10.1167/tvst.10.2.10. PMID: 34003894; PMCID: PMC7881274.

SIGALINGGING T, Perdamaian ABI, Romdhoniyyah DF, Prayogo ME, Wardhana FS,

Widayanti TW, Sasongko MB, Agni AN, Oka C, Supanji S. rs10737680 polymorphism in

complement factor H and neovascular age-related macular degeneration in Yogyakarta, Indonesia. Med Hypothesis Discov Innov Ophthalmol. 2021 Sep 23;11(2):71-76. doi: 10.51329/mehdiophthal1448. PMID: 37641789; PMCID: PMC10445304.

SORENSEN S, White K, Mak W, Zanibbi K, Tang W, O’Hearn A, Hegel MT. The macular

degeneration and aging study: Design and research protocol of a randomized trial for a

psychosocial intervention with macular degeneration patients. Contemp Clin Trials. 2015 May;42:68-77. doi: 10.1016/j.cct.2015.03.007. Epub 2015 Mar 24. PMID: 25812482; PMCID: PMC4450128.

STAHL A. The Diagnosis and Treatment of Age-Related Macular Degeneration. Dtsch

Arztebl Int. 2020 Jul 20;117(29-30):513-520. doi: 10.3238/arztebl.2020.0513. PMID:

; PMCID: PMC7588619.

THOMAS CJ, Mirza RG, Gill MK. Age-Related Macular Degeneration. Med Clin North Am. 2021 May;105(3):473-491. doi: 10.1016/j.mcna.2021.01.003. Epub 2021 Apr 2. PMID: 33926642.

TORRES RJA, Ferreira ALA. Age-related macular degeneration: an overview. Rev Bras

Oftalmol. 2021;80(5):e0038.

YORSTON D. Age-related macular degeneration (AMD): an introduction. Community Eye Health. 2025;37(125):7-8. Epub 2025 Jan 31. PMID: 40151374; PMCID: PMC11938193.

Published

2026-06-12

How to Cite

Araújo, M. B. de, Garcia, S. P., & Adamowski , E. de V. (2026). Degeneração macular, perda de visão central . Brazilian Journal of Implantology and Health Sciences, 8(6), 692–703. https://doi.org/10.36557/2674-8169.2026v8n6p692-703